Onel Fong Lores
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Onel Fong Lores has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Humberto Joaquin Morris Quevedo
Centro de Estudios de Biotecnología Industrial (CEBI), Universidad de Oriente, Ave. Patricio Lumumba s/n, Reparto Jiménez, Santiago de Cuba 90500, Cuba
4 shared publications - Clara Azalea Berenguer Rivas
Department of Pharmacy, Universidad de Oriente, Santiago de Cuba, Cuba, Cuba
3 shared publications - Yoandra Mora Tassé
Centro de Toxicología y Biomedicina (TOXIMED)
3 shared publications - Annarli Olivia Rodriguez Ferreiro
Department of Pharmacy, Universidad de Oriente, Santiago de Cuba, Cuba, Cuba
2 shared publications - Elizabeth Rodríguez Leblanch
Centro de Toxicología y Biomedicina (TOXIMED), Santiago de Cuba. Cuba
2 shared publications - Gabriel Llauradó
Centre of Studies for Industrial Biotechnology, University of Oriente, Ave. Patricio Lumumba s/n, Reparto Jiménez, Santiago de Cuba, 5, CP 90 500, Cuba
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by MDPI AG in Preprints.org
Integrative Experimental and In Silico Assessment of Antioxidant Activity, Hemocompatibility and ADMET Properties of Mimosa pudica L. (Fabaceae) Decoction
Mimosa pudica L., a pantropical medicinal herb rich in polyphenols, but also containing the non-protein amino acid mimosine with known cytotoxic properties, is a case for xenobiotic pharmacology, yet its safety profile remains inadequately characterized. In this study, we quantified the major metabolite classes of an aqueous decoction of M. pudica aerial parts, evaluated its in vitro hemocompatibility in human erythrocytes, and assessed its antioxidant activity using five cell-free assays. We also employed computational tools (ADMETlab 3.0, ProTox 3.0, SwissTargetPrediction, and InflamNat) to predict ADMET properties, toxicity alerts, and potential protein targets. The decoction showed high phenolic (316.41 ± 19.58 mg GAE/g) and flavonoid (122.99 ± 12.78 mg QE/g) contents, with mimosine levels of 2.11 ± 0.13 mg/g. Antioxidant activity was concentration-dependent, with the lowest IC₅₀ in the DPPH• assay (0.23 ± 0.02 mg/mL). Hemolysis remained below 9% at all tested concentrations (0.2–1.0 mg/mL), with an HC₅₀ > 1.0 mg/mL, consistent with biocompatibility criteria for plant extracts. In silico predictions indicated that most of flavonoids and phenolic acids complied with Lipinski's rule and showed a favorable oral bioavailability, but also, significant CYP450 inhibition and alerts for genotoxicity and nephrotoxicity. Predicted molecular targets included redox-modulatory proteins such as AKR1B1, XDH, NOX4, and GSK3B. Collectively, our results demonstrate that M. pudica is a complex mixture of xenobiotics with antioxidant effects, and suggest benefits and risks associated to their individual constituents. Further in vitro and in vivo studies are needed to validate these predictions and to determine whether M. pudica can be developed into safe and effective nutraceutical or pharmaceutical preparations.
- 8 October 2026
- Published by MDPI AG in Preprints.org
Open AccessIntegrative Experimental and In Silico Assessment of Antioxidant Activity, Hemocompatibility and ADMET Properties of Mimosa pudica L. (Fabaceae) Decoction
Mimosa pudica L., a pantropical medicinal herb rich in polyphenols, but also containing the non-protein amino acid mimosine with known cytotoxic properties, is a case for xenobiotic pharmacology, yet its safety profile remains inadequately characterized. In this study, we quantified the major metabolite classes of an aqueous decoction of M. pudica aerial parts, evaluated its in vitro hemocompatibility in human erythrocytes, and assessed its antioxidant activity using five cell-free assays. We also employed computational tools (ADMETlab 3.0, ProTox 3.0, SwissTargetPrediction, and InflamNat) to predict ADMET properties, toxicity alerts, and potential protein targets. The decoction showed high phenolic (316.41 ± 19.58 mg GAE/g) and flavonoid (122.99 ± 12.78 mg QE/g) contents, with mimosine levels of 2.11 ± 0.13 mg/g. Antioxidant activity was concentration-dependent, with the lowest IC₅₀ in the DPPH• assay (0.23 ± 0.02 mg/mL). Hemolysis remained below 9% at all tested concentrations (0.2–1.0 mg/mL), with an HC₅₀ > 1.0 mg/mL, consistent with biocompatibility criteria for plant extracts. In silico predictions indicated that most of flavonoids and phenolic acids complied with Lipinski's rule and showed a favorable oral bioavailability, but also, significant CYP450 inhibition and alerts for genotoxicity and nephrotoxicity. Predicted molecular targets included redox-modulatory proteins such as AKR1B1, XDH, NOX4, and GSK3B. Collectively, our results demonstrate that M. pudica is a complex mixture of xenobiotics with antioxidant effects, and suggest benefits and risks associated to their individual constituents. Further in vitro and in vivo studies are needed to validate these predictions and to determine whether M. pudica can be developed into safe and effective nutraceutical or pharmaceutical preparations.
- Open Access
- 20 June 2026
- Published by Editorial Primmate in Orange Journal
- Vol. 8 (14)
Potenciación selectiva de extractos foliares de Plectranthus neochilus Schltr. en la señalización NF-κB inducida por TNF-α en queratinocitos
Las dermatitis pediátricas constituyen un importante problema de salud en Cuba. Estas afecciones predominan durante los meses de verano y se caracterizan por alteraciones estructurales, metabólicas y funcionales de los queratinocitos. En este contexto, Plectranthus neochilus Schltr. utilizada tradicionalmente en África para el tratamiento de enfermedades cutáneas debido a sus propiedades cicatrizantes y antimicrobianas, representa una alternativa terapéutica prometedora. El objetivo de este estudio fue evaluar la citocompatibilidad y el efecto inmunomodulador de extractos foliares acuosos y etanólicos de P. neochilus sobre la vía de señalización de NF-κβ en células HaCaT. La actividad metabólica celular se determinó mediante el ensayo colorimétrico MTT y la actividad de NF-κβ mediante un ensayo de gen reportero de luciferasa. Ambos extractos mostraron un perfil de seguridad favorable, manteniendo una viabilidad celular superior al 78 % a la concentración máxima evaluada (512 µg/mL). Además, el ensayo de luciferasa expuso un fenómeno de coestimulación sinérgica altamente específico. En ausencia de estímulo, los extractos mantuvieron una actividad basal controlada de NF-κβ; sin embargo, en presencia de TNF-α incrementaron significativamente la señal bioluminiscente (1548,00 frente a 640,00 RLU). En conjunto, estos hallazgos sugieren que los extractos foliares de P. neochilus, probablemente debido a su elevado contenido de ácido rosmarínico, ejercen efectos citoprotectores e inmunomoduladores que podrían contribuir al fortalecimiento de la respuesta inmunitaria cutánea.
- 20 June 2026
- Published by Editorial Primmate in Orange Journal
- Vol. 8 (14)
Open AccessPotenciación selectiva de extractos foliares de Plectranthus neochilus Schltr. en la señalización NF-κB inducida por TNF-α en queratinocitos
Las dermatitis pediátricas constituyen un importante problema de salud en Cuba. Estas afecciones predominan durante los meses de verano y se caracterizan por alteraciones estructurales, metabólicas y funcionales de los queratinocitos. En este contexto, Plectranthus neochilus Schltr. utilizada tradicionalmente en África para el tratamiento de enfermedades cutáneas debido a sus propiedades cicatrizantes y antimicrobianas, representa una alternativa terapéutica prometedora. El objetivo de este estudio fue evaluar la citocompatibilidad y el efecto inmunomodulador de extractos foliares acuosos y etanólicos de P. neochilus sobre la vía de señalización de NF-κβ en células HaCaT. La actividad metabólica celular se determinó mediante el ensayo colorimétrico MTT y la actividad de NF-κβ mediante un ensayo de gen reportero de luciferasa. Ambos extractos mostraron un perfil de seguridad favorable, manteniendo una viabilidad celular superior al 78 % a la concentración máxima evaluada (512 µg/mL). Además, el ensayo de luciferasa expuso un fenómeno de coestimulación sinérgica altamente específico. En ausencia de estímulo, los extractos mantuvieron una actividad basal controlada de NF-κβ; sin embargo, en presencia de TNF-α incrementaron significativamente la señal bioluminiscente (1548,00 frente a 640,00 RLU). En conjunto, estos hallazgos sugieren que los extractos foliares de P. neochilus, probablemente debido a su elevado contenido de ácido rosmarínico, ejercen efectos citoprotectores e inmunomoduladores que podrían contribuir al fortalecimiento de la respuesta inmunitaria cutánea.
- Open Access
- 1 March 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (2) , 475-483
Repeated dose oral toxicity of Mimosa pudica L. (Fabaceae) aerial parts in mice
Context: Mimosa pudica L., belonging to the Fabaceae family, has been widely used in natural and traditional medicine because of its proven pharmacological properties. The present study examines through a preclinical toxicity assay, the safety of leaves and stems decoction of this plant used in popular medicine. Aims: To evaluate the oral toxicity at repeated doses of the M. pudica aerial parts. Methods: The toxicity assay was carried out using the limit test method by the administration of M. pudica decoction at repeated doses (1000 mg/kg of weight) for 28 days, to NMRI mice of both sexes. The body weight and clinical signs were assessed throughout the experimental period; and hematological and biochemical parameters, as well as, histopathological analysis of the main organs were evaluated at the end of the study. Results: The body weight of the animals treated with the plant decoction showed a significant decrease with respect to controls (p<0.05). The hematological parameters did not show alterations, while the biochemical markers exhibited a decrease in plasma proteins and an increase in glucose and the alanine aminotransferase enzyme activity. The histopathological study showed slight alterations in the brain, liver, lung, heart, thymus, and kidneys of experimental mice. Conclusions: The biochemical and histopathological results suggest that the decoction of M. pudica, administered orally at repeated doses, caused slight alterations that warn about the risks of its traditional use.
- 1 March 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (2) , 475-483
Open AccessRepeated dose oral toxicity of Mimosa pudica L. (Fabaceae) aerial parts in mice
Context: Mimosa pudica L., belonging to the Fabaceae family, has been widely used in natural and traditional medicine because of its proven pharmacological properties. The present study examines through a preclinical toxicity assay, the safety of leaves and stems decoction of this plant used in popular medicine. Aims: To evaluate the oral toxicity at repeated doses of the M. pudica aerial parts. Methods: The toxicity assay was carried out using the limit test method by the administration of M. pudica decoction at repeated doses (1000 mg/kg of weight) for 28 days, to NMRI mice of both sexes. The body weight and clinical signs were assessed throughout the experimental period; and hematological and biochemical parameters, as well as, histopathological analysis of the main organs were evaluated at the end of the study. Results: The body weight of the animals treated with the plant decoction showed a significant decrease with respect to controls (p<0.05). The hematological parameters did not show alterations, while the biochemical markers exhibited a decrease in plasma proteins and an increase in glucose and the alanine aminotransferase enzyme activity. The histopathological study showed slight alterations in the brain, liver, lung, heart, thymus, and kidneys of experimental mice. Conclusions: The biochemical and histopathological results suggest that the decoction of M. pudica, administered orally at repeated doses, caused slight alterations that warn about the risks of its traditional use.
- Open Access
- 8 July 2024
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina Veterinaria y de Zootecnia
Evaluation of dermal and ocular safety of natural products based on Murraya paniculata, Eucalyptus sp. and Indigofera suffruticosa Mill. in New Zealand rabbits
This study was conducted to evaluate the acute dermal and ocular irritant potential of three natural products obtained from medicinal plants Murraya paniculata (PNI), Eucalyptus sp. (PNII), and Indigofera suffruticosa Mill. (PNIII) for topical use in veterinary medicine. For the assessment of acute dermal and ocular irritability, methodologies from the Organization for Economic Cooperation and Development (OECD) were employed through guidelines 404 and 405, respectively, using New Zealand albino rabbits. The evaluated products showed no signs or symptoms of irritation/corrosion on the skin and eyes, exhibiting dermal and ocular irritation indices within the range of classification of non-irritating substances, according to the OECD Harmonized Integrated Classification System.
- 8 July 2024
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina Veterinaria y de Zootecnia
Open AccessEvaluation of dermal and ocular safety of natural products based on Murraya paniculata, Eucalyptus sp. and Indigofera suffruticosa Mill. in New Zealand rabbits
This study was conducted to evaluate the acute dermal and ocular irritant potential of three natural products obtained from medicinal plants Murraya paniculata (PNI), Eucalyptus sp. (PNII), and Indigofera suffruticosa Mill. (PNIII) for topical use in veterinary medicine. For the assessment of acute dermal and ocular irritability, methodologies from the Organization for Economic Cooperation and Development (OECD) were employed through guidelines 404 and 405, respectively, using New Zealand albino rabbits. The evaluated products showed no signs or symptoms of irritation/corrosion on the skin and eyes, exhibiting dermal and ocular irritation indices within the range of classification of non-irritating substances, according to the OECD Harmonized Integrated Classification System.
- Open Access
- 11 May 2024
- Published by Editorial Primmate in Orange Journal
- Vol. 6 (11) , 43-55
Ethnopharmacological study of medicinal plants with activity on the Central nervous system in the Eastern Region of Cuba
In the eastern region of Cuba, there is a traditional use of medicinal plants for various pharmacological purposes, although an inventory of these plant species necessary for the future search for new phytomedicines does not exist in all cases. This is the case for those used to treat central nervous system (CNS) disorders. To evaluate the traditional knowledge in two regions of Eastern Cuba: Santiago de Cuba and Holguín, regarding the use of medicinal plants with sedative, hypnotic, and anxiolytic effects, an ethnopharmacological study was conducted in two health areas of the main municipalities of these two provinces. A total of 400 people were surveyed, performing the socio-demographic characterization of the evaluated population as well as the qualitative characterization and evaluation of quantitative ethnopharmacological indicators such as the use value index and the significant use level of the medicinal plants used. The surveyed population in both provinces was predominantly female and over 60 years old, with a high level of preparation and professional training. A total of 27 plants were reported in the interviews conducted among the 1637 citations obtained, with similar results between the two provinces. The highest number of citations in both regions corresponded to plants used as sedatives, followed by hypnotics, and finally anxiolytics. Among the most used parts of these plants, the use of leaves prepared in the form of infusions predominated. Of the 8 plant species with the highest acceptance by the population, the plants P. neochilus, J. pectoralis, L. inermis, and P. incarnata obtained the best values for the evaluated ethnopharmacological indicators.
- 11 May 2024
- Published by Editorial Primmate in Orange Journal
- Vol. 6 (11) , 43-55
Open AccessEthnopharmacological study of medicinal plants with activity on the Central nervous system in the Eastern Region of Cuba
In the eastern region of Cuba, there is a traditional use of medicinal plants for various pharmacological purposes, although an inventory of these plant species necessary for the future search for new phytomedicines does not exist in all cases. This is the case for those used to treat central nervous system (CNS) disorders. To evaluate the traditional knowledge in two regions of Eastern Cuba: Santiago de Cuba and Holguín, regarding the use of medicinal plants with sedative, hypnotic, and anxiolytic effects, an ethnopharmacological study was conducted in two health areas of the main municipalities of these two provinces. A total of 400 people were surveyed, performing the socio-demographic characterization of the evaluated population as well as the qualitative characterization and evaluation of quantitative ethnopharmacological indicators such as the use value index and the significant use level of the medicinal plants used. The surveyed population in both provinces was predominantly female and over 60 years old, with a high level of preparation and professional training. A total of 27 plants were reported in the interviews conducted among the 1637 citations obtained, with similar results between the two provinces. The highest number of citations in both regions corresponded to plants used as sedatives, followed by hypnotics, and finally anxiolytics. Among the most used parts of these plants, the use of leaves prepared in the form of infusions predominated. Of the 8 plant species with the highest acceptance by the population, the plants P. neochilus, J. pectoralis, L. inermis, and P. incarnata obtained the best values for the evaluated ethnopharmacological indicators.
- Open Access
- 26 July 2023
- Published by Editorial Primmate in Orange Journal
- Vol. 5 (9) , 16-22
Crystal violet in the histochemical diagnosis of Helicobacter pylori
- 26 July 2023
- Published by Editorial Primmate in Orange Journal
- Vol. 5 (9) , 16-22
Open AccessCrystal violet in the histochemical diagnosis of Helicobacter pylori
- Open Access
- 8 September 2022
- Published by Editorial Primmate in Orange Journal
- Vol. 4 (7) , 4-15
Potencialidades farmacológicas de plantas medicinales cubanas como base para la conservación de su biodiversidad
Preservar la biodiversidad vegetal ha cobrado una atención considerable tanto por la comunidad científica como en el desarrollo de políticas públicas. La Organización Mundial de la Salud, por tal motivo, fomenta las investigaciones relacionadas con la utilización de las plantas medicinales. Este trabajo tiene como objetivo: describir las potencialidades farmacológicas de plantas medicinales cubanas como base para la conservación de su biodiversidad. Se realizó un estudio descriptivo-retrospectivo, en el cual se analizaron las diferentes especies medicinales a la cuales se les han realizado estudios preclínicos y perfiles fármaco-toxicológicos en el Centro de Toxicología y Biomedicina (TOXIMED). Además, se procesaron todos los artículos publicados relacionados con las plantas estudiadas. De cada producción científica se tuvieron en cuenta las siguientes variables cualitativas: título, autores, revista, indexación y entidades participantes. Se describieron las potencialidades farmacológicas de 24 plantas medicinales, contabilizándose un total de 29 estudios preclínicos realizados, de ellos 24 (82,7 %) ensayos toxicológicos y 5 (17,2 %) farmacológicos. A 12 especies distintas se les han realizado perfiles fármaco-toxicológicos, los cuales han formado parte del registro y comercialización de diferentes fitofármacos realizados principalmente por la Empresa comercializadora del Grupo Empresarial LABIOFAM. Estos estudios han originado un total de 19 publicaciones científicas y sin dudas contribuyen a la realización de estudios de fase II tanto farmacológicos como toxicológicos. Además de la utilización segura y conservación de estas especies.
- 8 September 2022
- Published by Editorial Primmate in Orange Journal
- Vol. 4 (7) , 4-15
Open AccessPotencialidades farmacológicas de plantas medicinales cubanas como base para la conservación de su biodiversidad
Preservar la biodiversidad vegetal ha cobrado una atención considerable tanto por la comunidad científica como en el desarrollo de políticas públicas. La Organización Mundial de la Salud, por tal motivo, fomenta las investigaciones relacionadas con la utilización de las plantas medicinales. Este trabajo tiene como objetivo: describir las potencialidades farmacológicas de plantas medicinales cubanas como base para la conservación de su biodiversidad. Se realizó un estudio descriptivo-retrospectivo, en el cual se analizaron las diferentes especies medicinales a la cuales se les han realizado estudios preclínicos y perfiles fármaco-toxicológicos en el Centro de Toxicología y Biomedicina (TOXIMED). Además, se procesaron todos los artículos publicados relacionados con las plantas estudiadas. De cada producción científica se tuvieron en cuenta las siguientes variables cualitativas: título, autores, revista, indexación y entidades participantes. Se describieron las potencialidades farmacológicas de 24 plantas medicinales, contabilizándose un total de 29 estudios preclínicos realizados, de ellos 24 (82,7 %) ensayos toxicológicos y 5 (17,2 %) farmacológicos. A 12 especies distintas se les han realizado perfiles fármaco-toxicológicos, los cuales han formado parte del registro y comercialización de diferentes fitofármacos realizados principalmente por la Empresa comercializadora del Grupo Empresarial LABIOFAM. Estos estudios han originado un total de 19 publicaciones científicas y sin dudas contribuyen a la realización de estudios de fase II tanto farmacológicos como toxicológicos. Además de la utilización segura y conservación de estas especies.
- Open Access
- 1 November 2021
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 9 (6) , 892-904
Cytoprotective activity of extracts from Adelia ricinella L. aerial parts
Context: Several factors can affect the erythrocyte cell membrane integrity targeting important hematological alterations that can be avoided by the cytoprotective effect offered by some plant extracts. Aims: To evaluate the cytoprotective activity of Adelia ricinella L. extracts on red blood cells (RBCs) membrane after hypotonic and oxidative treatments. Methods: Total phenols and flavonoid contents were spectrophotometrically determined in three extracts: AR1 (ethanol 95%), AR2 (ethanol 50%), and AR3 (aqueous extract). Luteolin and apigenin were quantified using HPLC-DAD techniques. Hypotonic erythrocyte membrane stabilizing activity of plant extracts, their antioxidant protective effect on H2O2-induced cell damage, and cytotoxicity on Vero cells were explored. Control cells were treated with sodium diclofenac or ascorbic acid. Results: AR2 extract showed the highest values of total phenols/flavonoids, as well as, for luteolin and apigenin with 207.5 and 1.86 µg/mL respectively. The extracts did not exert spontaneous hemolysis following the INVITOX protocol, presumably by the protective effect of high flavonoid content. A concentration-dependent pattern was observed on the hypotonic erythrocyte membrane stabilizing assay, in which both ethanol extracts but mainly AR1 (IC50 = 16.46 µg/mL) showed a significant activity with lower IC50 values than diclofenac-control group. On the other hand, AR2 (IC50 = 17.49 µg/mL) displayed the most potent cytoprotective effect on RBCs after H2O2-induced cell damage. Adelia ricinella extracts were not cytotoxic to mammalian Vero cells (IC50 > 256 μg/mL). Conclusions: The study suggests that Adelia ricinella extracts can promote erythrocyte cytoprotection by protecting both membrane layers, thus preventing potential hematological alterations induced by oxidizing damage and probably, in inflammation-related diseases.
- 1 November 2021
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 9 (6) , 892-904
Open AccessCytoprotective activity of extracts from Adelia ricinella L. aerial parts
Context: Several factors can affect the erythrocyte cell membrane integrity targeting important hematological alterations that can be avoided by the cytoprotective effect offered by some plant extracts. Aims: To evaluate the cytoprotective activity of Adelia ricinella L. extracts on red blood cells (RBCs) membrane after hypotonic and oxidative treatments. Methods: Total phenols and flavonoid contents were spectrophotometrically determined in three extracts: AR1 (ethanol 95%), AR2 (ethanol 50%), and AR3 (aqueous extract). Luteolin and apigenin were quantified using HPLC-DAD techniques. Hypotonic erythrocyte membrane stabilizing activity of plant extracts, their antioxidant protective effect on H2O2-induced cell damage, and cytotoxicity on Vero cells were explored. Control cells were treated with sodium diclofenac or ascorbic acid. Results: AR2 extract showed the highest values of total phenols/flavonoids, as well as, for luteolin and apigenin with 207.5 and 1.86 µg/mL respectively. The extracts did not exert spontaneous hemolysis following the INVITOX protocol, presumably by the protective effect of high flavonoid content. A concentration-dependent pattern was observed on the hypotonic erythrocyte membrane stabilizing assay, in which both ethanol extracts but mainly AR1 (IC50 = 16.46 µg/mL) showed a significant activity with lower IC50 values than diclofenac-control group. On the other hand, AR2 (IC50 = 17.49 µg/mL) displayed the most potent cytoprotective effect on RBCs after H2O2-induced cell damage. Adelia ricinella extracts were not cytotoxic to mammalian Vero cells (IC50 > 256 μg/mL). Conclusions: The study suggests that Adelia ricinella extracts can promote erythrocyte cytoprotection by protecting both membrane layers, thus preventing potential hematological alterations induced by oxidizing damage and probably, in inflammation-related diseases.
- 1 January 2018
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 211, 29-37
Toxicological evaluation of an aqueous suspension from leaves and stems of Petiveria alliacea L. (Phytolaccaceae)
- 1 January 2018
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 211, 29-37
Toxicological evaluation of an aqueous suspension from leaves and stems of Petiveria alliacea L. (Phytolaccaceae)
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 1456-1463
Oral administration of an aqueous extract from the oyster mushroom Pleurotus ostreatus enhances the immunonutritional recovery of malnourished mice
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 1456-1463
Oral administration of an aqueous extract from the oyster mushroom Pleurotus ostreatus enhances the immunonutritional recovery of malnourished mice